Have you ever wondered whether the materials in life-saving medical devices can truly stand the test of time? In the rapidly evolving field of medical technology, the demands on materials have never been higher. Plastics used in medical equipment must not only exhibit exceptional physical properties but also maintain stability and safety when in contact with the human body, undergoing repeated sterilization, or facing complex environmental challenges.

For decades, a class of additives called phthalates—particularly DEHP—have been widely used to enhance plastic flexibility. However, growing global concerns about their potential health risks have created an urgent need for safer alternatives, especially in medical applications.

Nature's Answer to Medical-Grade Plastics

Aurorium's Citroflex™ B-6, a corn-derived citrate ester plasticizer, represents a breakthrough in phthalate-free solutions for medical plastics. Devices requiring implantation or prolonged patient contact—such as catheters—demand materials with superior softness, flexibility, and biocompatibility. While polyvinyl chloride (PVC) offers excellent processability, its inherent rigidity has limited its potential for high-end medical applications without plasticizers.

Citroflex™ B-6 not only delivers exceptional plasticizing effects, granting PVC remarkable softness and elasticity, but also boasts an impeccable toxicological profile. This significantly reduces potential health risks compared to traditional plasticizers like DEHP, aligning with the global shift toward "phthalate-free" medical products.

Performance That Exceeds Expectations

Far from being just a DEHP substitute, Citroflex™ B-6 outperforms its predecessor in several critical metrics. Specifically formulated for medical applications, it withstands repeated sterilization while maintaining excellent corrosion resistance and temperature adaptability. This ensures devices retain their flexibility even in extreme conditions, enhancing patient comfort and clinical usability.

The plasticizer enables seamless "drop-in" replacement of DEHP in existing PVC formulations, allowing manufacturers to meet stringent North American and European regulations without costly production overhauls. Its exceptional low-temperature performance—demonstrated by a significantly lower brittle transition temperature (-33.5°C vs. DEHP's -24.5°C)—proves particularly valuable for blood bags and other devices requiring cold storage.

Head-to-Head: Citroflex™ B-6 vs. DEHP

The following comparison highlights key performance differences (data based on medical-grade PVC films containing 50 phr plasticizer, 2.5 phr stabilizer, and 0.25 phr lubricant):

Sustainability Meets Compliance

Beyond performance advantages, Citroflex™ B-6's bio-based origin and biodegradability address growing demands for sustainable medical materials. Its compatibility with end-of-life biodegradable polymer systems allows manufacturers to meet environmental goals without compromising safety or functionality—a critical advantage as regulators worldwide tighten restrictions on conventional plasticizers.

With superior low volatility, reduced migration in aqueous environments, and exceptional cold flexibility, Citroflex™ B-6 shows particular promise for medical tubing, IV bags, and specialty films. As global standards for medical device safety and sustainability continue to rise, such innovations may redefine expectations for medical-grade plastics.